Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07290387 · ClinicalTrials.gov registry record · NA

Tele-Savvy for Latino Caregivers

A NA study, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
64
Enrollment target

NCT07290387: Recruiting NA study, sponsored by University of Rochester.

NCT07290387 is a NA study that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07290387, a NA study, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target

Study Summary

Latino caregivers of individuals with Alzheimer's disease and related dementias experience high levels of stress burden and depressive symptoms and are underrepresented in caregiver intervention research. Tele Savvy is an evidence based caregiver education program that focuses on developing caregiver mastery skills. This study aims to culturally adapt the Tele Savvy intervention for Latino caregivers and evaluate its preliminary efficacy in a Stage 1b single arm clinical trial. The intervention is delivered remotely and includes weekly group sessions and asynchronous instructional videos. Primary outcomes focus on caregiver mastery with secondary outcomes including stress burden depressive symptoms and self efficacy.

Primary Outcome

Caregiver mastery is measured using two Pearlin Caregivers' Stress subscales: Caregiving Competence and Confidence and Management of Situation. Each subscale consists of four Likert type items. Item responses are scored according to published scoring instructions and summed to produce a total caregiver mastery score for each participant at each assessment time point. The outcome is defined as the mean change in the total caregiver mastery score from baseline to three months post intervention acr

Interventions

  • BEHAVIORAL Tele Savvy for Latino Caregivers

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2026-04-17
Est. Completion 2027-05-31
Phase NA
University of Rochester

636 total trials

What NCT07290387 shows while recruiting

NCT07290387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Tele Savvy for Latino Caregivers is the first listed.

NCT07290387 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07290387 about?

NCT07290387 is a clinical study titled "Tele-Savvy for Latino Caregivers". Latino caregivers of individuals with Alzheimer's disease and related dementias experience high levels of stress burden and depressive symptoms and are underrepresented in caregiver intervention research. Tele Savvy is an evidence based caregiver education program that focuses on developing caregive...

What is the current status of trial NCT07290387?

This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2026-04-17. Estimated completion is 2027-05-31.

What interventions are being tested in trial NCT07290387?

The interventions under investigation include: Tele Savvy for Latino Caregivers (BEHAVIORAL).

Who is sponsoring clinical trial NCT07290387?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07290387's enrollment target sits among peer trials

64 1147th of 2000 higher than 844 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07290387, the US trial registry maintained by the National Library of Medicine. NCT07290387 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.